Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients (2013)
- Authors:
- Willrich, Maria Alice Vieira
- Rodrigues, Alice Cristina
- Cerda, Alvaro
- Genvigir, Fabiana Dalla Vecchia
- Arazi, Simone Sorkin
- Dórea, Egidio Lima
- Bernik, Marcia Martins Silveira
- Bertolami, Marcelo Chiara - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Faludi, André Arpad - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Largura, Alvaro
- Baudhuin, Linnea M
- Bryant, Sandra C
- Hirata, Mario Hiroyuki
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: DOREA, EGIDIO LIMA - HU ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: HU; FCF
- DOI: 10.1016/j.cca.2013.03.007
- Subjects: EXPRESSÃO GÊNICA; HIPERCOLESTEROLEMIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinica Chimica Acta
- ISSN: 0009-8981
- Volume/Número/Paginação/Ano: v. 421, p. 157-163, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WILLRICH, Maria Alice Vieira et al. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, v. 421, p. 157-163, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2013.03.007. Acesso em: 03 mar. 2026. -
APA
Willrich, M. A. V., Rodrigues, A. C., Cerda, A., Genvigir, F. D. V., Arazi, S. S., Dórea, E. L., et al. (2013). Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, 421, 157-163. doi:10.1016/j.cca.2013.03.007 -
NLM
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.[citado 2026 mar. 03 ] Available from: https://doi.org/10.1016/j.cca.2013.03.007 -
Vancouver
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.[citado 2026 mar. 03 ] Available from: https://doi.org/10.1016/j.cca.2013.03.007 - Leptin receptor gene polymorphisms are associated with adiposity and metabolic alterations in Brazilian individuals
- Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
- CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy
Informações sobre o DOI: 10.1016/j.cca.2013.03.007 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
